Philip Galebach

The burden of hepatorenal syndrome among commercially insured and Medicare patients in the United States

J. Bradford Rice, Alan G. White, Philip Galebach et al. · Current Medical Research and Opinion · 2017 · 32 citations

Public Affairs, Insurance, Internal Medicine +16

Assessing utility values for treatment-related health states of acute myeloid leukemia in the United States

Eytan M. Stein, Min Yang, Annie Guérin et al. · Health and Quality of Life Outcomes · 2018 · 26 citations · Full text

Pharmacy, Pharmacoeconomics, Health Economics +16

Healthcare resource utilization and work loss in dermatomyositis and polymyositis patients in a privately-insured US population

J. Bradford Rice, Alan G. White, Andrea Lopez et al. · Journal of Medical Economics · 2016 · 25 citations

Pharmacy, Dermatology, Internal Medicine +17

Treatment, overall survival, and costs in patients with<i>ALK</i>-positive non-small-cell lung cancer after crizotinib monotherapy

A. Guérin, Medha Sasané, Heather A. Wakelee et al. · Current Medical Research and Opinion · 2015 · 24 citations

Medicine, Oncology, Pharmacoeconomics +16

Treatment patterns and outcomes in <scp>BRAF</scp> V600E‐mutant melanoma patients with brain metastases receiving vemurafenib in the real‐world setting

Geoffrey T. Gibney, Geneviève Gauthier, Charles Ayas et al. · Cancer Medicine · 2015 · 23 citations · Full text

Medicine, Oncology, Pharmacotherapy +17